Kluger HM - Search Results

1

Zito CR, Kluger HM. Zito CR, et al. Among authors: kluger hm. J Cell Biochem. 2012 Mar;113(3):725-34. doi: 10.1002/jcb.23402. J Cell Biochem. 2012. PMID: 22006439 Review.

2

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.

Kluger HM, McCarthy MM, Alvero AB, Sznol M, Ariyan S, Camp RL, Rimm DL, Mor G. Kluger HM, et al. J Transl Med. 2007 Jan 26;5:6. doi: 10.1186/1479-5876-5-6. J Transl Med. 2007. PMID: 17257402 Free PMC article.

3

Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer.

Acquavella N, Kluger H, Rhee J, Farber L, Tara H, Ariyan S, Narayan D, Kelly W, Sznol M. Acquavella N, et al. J Immunother. 2008 Jul-Aug;31(6):569-76. doi: 10.1097/CJI.0b013e318177a4ba. J Immunother. 2008. PMID: 18528297

4

Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.

Jilaveanu L, Zito C, Lee SJ, Nathanson KL, Camp RL, Rimm DL, Flaherty KT, Kluger HM. Jilaveanu L, et al. Among authors: kluger hm. Clin Cancer Res. 2009 Feb 1;15(3):1076-85. doi: 10.1158/1078-0432.CCR-08-2280. Clin Cancer Res. 2009. PMID: 19188183 Free PMC article. Clinical Trial.

5

Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.

Aziz SA, Davies M, Pick E, Zito C, Jilaveanu L, Camp RL, Rimm DL, Kluger Y, Kluger HM. Aziz SA, et al. Among authors: kluger y, kluger hm. Clin Cancer Res. 2009 May 1;15(9):3029-36. doi: 10.1158/1078-0432.CCR-08-2768. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383818 Free PMC article.

6

C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.

Jilaveanu LB, Zito CR, Aziz SA, Conrad PJ, Schmitz JC, Sznol M, Camp RL, Rimm DL, Kluger HM. Jilaveanu LB, et al. Among authors: kluger hm. Clin Cancer Res. 2009 Sep 15;15(18):5704-13. doi: 10.1158/1078-0432.CCR-09-0198. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737955 Free PMC article.

7

Chemotherapy and biologic therapies for melanoma: do they work?

Jilaveanu LB, Aziz SA, Kluger HM. Jilaveanu LB, et al. Among authors: kluger hm. Clin Dermatol. 2009 Nov-Dec;27(6):614-25. doi: 10.1016/j.clindermatol.2008.09.020. Clin Dermatol. 2009. PMID: 19880049 Review.

8

Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.

Aziz SA, Jilaveanu LB, Zito C, Camp RL, Rimm DL, Conrad P, Kluger HM. Aziz SA, et al. Among authors: kluger hm. Clin Cancer Res. 2010 Dec 15;16(24):6029-39. doi: 10.1158/1078-0432.CCR-10-1490. Clin Cancer Res. 2010. PMID: 21169255 Free PMC article.

9

Ipilimumab: a promising immunotherapy for melanoma.

Thumar JR, Kluger HM. Thumar JR, et al. Among authors: kluger hm. Oncology (Williston Park). 2010 Dec;24(14):1280-8. Oncology (Williston Park). 2010. PMID: 21294471 Free article. Review.

10

In vitro studies of dasatinib, its targets and predictors of sensitivity.

Jilaveanu LB, Zito CR, Aziz SA, Chakraborty A, Davies MA, Camp RL, Rimm DL, Dudek A, Sznol M, Kluger HM. Jilaveanu LB, et al. Among authors: kluger hm. Pigment Cell Melanoma Res. 2011 Apr;24(2):386-9. doi: 10.1111/j.1755-148X.2011.00835.x. Pigment Cell Melanoma Res. 2011. PMID: 21320292 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page